Evidence map›Paper›PMID 41428450›Full record

ArticlePain medicine (Malden, Mass.)2026

Prediction of opioid use disorder among patients with chronic non-cancer pain receiving long-term opioid therapy.

Christal N Davis, Yoonjae Lee, Martin D Cheatle

Abstract read
In one paragraph

Article in Pain medicine (Malden, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christal N DavisMental Illness Research, Education, and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, United States.ORCID 0000-0003-3974-5598
Yoonjae LeeSchool of Nursing, University of Pennsylvania, Philadelphia, PA, United States.ORCID 0000-0002-7115-4192
Martin D CheatleDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.ORCID 0000-0002-6793-6474

Funding

Individualized Care for At Risk Older AdultsT32NR009356 · NINR · UNIVERSITY OF PENNSYLVANIA · PI Lauren M Massimo, MARY D NAYLOR · 2007 to 2026
$7.8M
Clinical and Genetic Characteristics of Opioid Addiction in Chronic PainR01DA032776 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CHEATLE, MARTIN D · 2012 to 2016
$2.9M
Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentNIDA NIH HHS R01 DA032776NIDA NIH HHS R01 DA032776-05NIH HHSNINR NIH HHS T32 NR009356Philadelphia Veterans Affairs Mental Illness Research, Education, and Clinical Center
6 · The paper itself

Abstract

objectiveAssessing opioid use disorder risk in patients prescribed long-term opioid therapy for management of chronic non-cancer pain is critical for prevention and early intervention.

designCase-control study.

settingPain management and primary care clinics, and substance use treatment facilities. SUBJECTS: Participants are 1300 patients with chronic non-cancer pain (59.68% women; mean age = 49.03 years), 409 of whom developed opioid use disorder.

methodsWe compared the performance of 3 machine learning models that used the Opioid Risk Tool for Opioid Use Disorder alone with those that incorporated an expanded set of clinical predictors.

resultsThe Opioid Risk Tool for Opioid Use Disorder showed strong performance (precision = 0.91; specificity = 0.96). Models that incorporated additional predictors showed improved performance on precision-recall area under the curve and F1 scores, particularly the random forest and eXtreme Gradient Boosting models. Aside from the Opioid Risk Tool for Opioid Use Disorder, the most important features in the expanded models were nicotine dependence, marital status, opioid misuse behaviors, and pain interference and catastrophizing.

conclusionsA stepwise approach that employs the Opioid Risk Tool for Opioid Use Disorder as a preliminary screener followed by a more in-depth assessment of clinical predictors among high-risk individuals may offer a feasible strategy to optimize efficiency and precision in risk stratification. Future work should refine and validate this framework in diverse population and care settings, as well as examine its integration into clinical workflow to enhance the identification of chronic non-cancer pain patients at risk for opioid use disorder.

Indexed as

Analgesics, OpioidChronic PainOpioid-Related DisordersAdultCase-Control StudiesFemaleHumansMachine LearningMaleMiddle AgedRisk FactorsAnalgesics, Opioidchronic non-cancer painlong-term opioid therapymachine learningopioid use disorder

Identifiers

PMID41428450
PMCPMC12865100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.